Does Medicare cover Ozempic or Wegovy?

It depends entirely on why the drug is prescribed. By law, Medicare drug coverage (Part D) cannot pay for a medication when it is used only for weight loss. But the very same GLP-1 medication can be covered when it is prescribed for a different, FDA-approved medical reason. So the honest answer is: Ozempic and Wegovy may be covered by a Medicare Part D drug plan for certain conditions, but not for weight loss on its own.

The rule that decides everything: the reason for the prescription

Here is the core of it. Federal law specifically excludes “agents when used for weight loss” from what a Part D plan is allowed to cover. That exclusion has been on the books for years, and it is why a drug prescribed purely to help someone lose weight is not a covered Part D drug.

This is why two people can be prescribed the exact same medication and get opposite answers from Medicare. The one whose prescription is tied to a covered medical diagnosis can have it run through their drug plan; the one whose prescription is written only to lose weight cannot, no matter how much they might benefit from it. It is not the pharmacy or the plan being difficult — it is the federal definition of what counts as a covered Part D drug.

The important nuance is that the exclusion is about the use, not the drug itself. When one of these medications is prescribed for a separate, FDA-approved indication that is not excluded, a Part D plan is allowed to cover it. Two clear examples:

  • Ozempic prescribed for type 2 diabetes — a covered use, because it treats a medical condition, not weight.
  • Wegovy prescribed to reduce the risk of a heart attack or stroke in adults with established cardiovascular disease who also have obesity or overweight — a use the FDA has approved, which opened the door for Part D plans to cover it for that purpose.

Coverage in your specific case still depends on your plan and your prescriber documenting the covered diagnosis. But the principle is simple: same drug, different reason, different answer.

These are Part D drugs, not Part B

Ozempic and Wegovy are self-administered prescription drugs, so they fall under Medicare Part D, the prescription drug side of Medicare — not Part B. That matters because there is no single Medicare cost figure for them; what you pay depends on the drug plan you have and how it lists the medication. Our broader guide to how Medicare covers prescriptions explains how Part D plans decide what they pay for and how your share is calculated. Many people get this coverage through a stand-alone Part D plan, while others get it built into a Medicare Advantage plan that includes drug coverage.

A temporary 2026 program to be aware of

There is one new development worth knowing about. Medicare is running a temporary demonstration program — scheduled to run from July 1, 2026 through December 31, 2027 — that lets certain eligible Part D members get some GLP-1 medications prescribed for weight reduction at a $50 per month copay. It is a limited, time-boxed pilot, and people who already qualify for a GLP-1 under the regular Part D rules (for example, for type 2 diabetes) are not eligible for it. Because the exact eligibility details and drug list are set by Medicare and can change, do not assume you qualify — confirm the current specifics on Medicare.gov or with your plan before counting on it.

What you can do if the drug is not covered for you

If your prescription is for weight loss alone, a Part D plan will not cover it, and you would pay full price out of pocket. A few practical steps help: talk with your doctor about whether you have a covered medical indication, ask whether a covered alternative fits your situation, and look into manufacturer or pharmacy savings programs. If cost is the real barrier, it is also worth checking whether you qualify for programs that help pay for Medicare and prescription costs, which can meaningfully lower what lower-income beneficiaries pay for drugs. Our local Medicare team serving Concord can help you review your current drug plan against your prescriptions.

It also helps to bring your full medication list and your recent diagnoses to the conversation, because a covered indication has to be documented by your prescriber, not just mentioned. If a covered use does apply to you, your doctor’s office may need to submit information to the plan before it will pay — a normal step for higher-cost medications. And if none of the covered uses fit your situation, being clear-eyed about that up front saves you from banking on coverage that will not come through.

Why the right drug plan matters here

Two Part D plans can treat the same medication very differently — one may cover it with reasonable cost-sharing, another may place restrictions on it or not list it at all. That is exactly the kind of difference that gets missed when someone keeps the same plan year after year without reviewing it. A yearly check of your drug plan against the medications you actually take is the single most effective way to avoid overpaying, especially for higher-cost drugs like these.

If you are choosing coverage for the first time, or you have started a new medication since you last picked a plan, that is exactly the moment to have your drug list reviewed — rather than assuming last year’s choice still fits this year’s prescriptions and this year’s plan rules.

What you’d pay: why there is no single number

Because Ozempic and Wegovy are covered under the prescription-drug side of Medicare, there is no fixed Medicare cost-share for them the way there is for a Part B service. What you pay for a covered GLP-1 is set by your particular drug plan — two people with the same prescription can pay very different amounts depending on which plan they have and how that plan covers the medication. That is the opposite of a one-size figure, and it is exactly why the plan you choose matters so much for a higher-cost drug like these.

The one fixed number in this picture is tied to the temporary demonstration described above: during its July 1, 2026 through December 31, 2027 window, eligible members can get certain GLP-1s prescribed for weight reduction at a $50 per month copay. Outside that specific program, your cost falls back to whatever your drug plan charges for the medication when it is covered for a qualifying medical reason. None of this is a promise that any given plan covers any given drug — it is simply how the pricing works, which is why the practical question is always: how does my plan handle this drug, for my diagnosis?

How to check whether your plan covers it for your situation

Turning the general rule into a real answer for you comes down to a few concrete steps:

  • Pin down the reason on the prescription. A covered use — such as type 2 diabetes for Ozempic, or the approved cardiovascular use for Wegovy — has to be documented by your prescriber, not just mentioned in passing.
  • Ask your plan how it covers this specific drug and what your share would be. Coverage and cost can differ sharply from one plan to the next, so the only reliable answer comes from checking your own plan against your own prescription.
  • Expect a possible approval step. For higher-cost medications, your prescriber’s office may need to send information to the plan before it will pay — a normal part of the process, not a red flag.
  • Bring your full medication list and recent diagnoses to any review, since a covered indication has to be on the record for the drug to run through your plan.

If none of the covered uses fit your situation, it is better to know that up front than to bank on coverage that will not arrive — and to look instead at the savings options and assistance programs mentioned earlier.

When coverage comes down to the details

GLP-1 drugs are a good example of a bigger truth about Medicare: the answer often hinges on the specific circumstances rather than the item itself. The same “it depends on the details” logic shows up all over the program. Whether Medicare helps with dental implants, for instance, turns on whether the work is tied to a covered medical procedure — not on the implant itself — much as your GLP-1 answer turns on the diagnosis behind the prescription. And whether an ambulance trip is covered depends on medical necessity and which part of Medicare applies, not simply on the fact that you rode in one. Seeing that pattern — coverage following the reason and the rules, not just the name of the service — is what makes it easier to plan around Medicare instead of being surprised by it.

How The Jordan Insurance Agency helps

The Jordan Insurance Agency is an independent, full-time, licensed insurance agency in Charlotte, North Carolina, serving clients across the state. Because we are independent, we can compare the Part D and Medicare Advantage drug options available to you and see how each one handles the specific medications on your list — then explain, in plain English, what you would actually pay. We are careful never to promise that any one plan covers any one drug; instead we help you match your prescriptions to the plan that fits them best, and we re-check it every year at renewal because drug coverage changes annually. Our help costs you nothing extra, since your premium is the same whether you enroll on your own or through our office.

Reviewed for clarity and Medicare insurance context: Billy Jordan Jr., President, The Jordan Insurance Agency. Meet our team. Last reviewed September 4, 2026.

Next step: If you want your prescriptions matched to the drug plan that covers them best, explore our Medicare guidance and plan support.